Oryzon Genomics SA (ORYZF, $2.91) gained +7 and reached a new high over the last three months. By comparison, the broader Biotechnology Industry returned -1 over the same period of time. A.I.dvisor analyzed 852 stocks in the Biotechnology Industry over the same period of time and found that of them (2) were in an Uptrend while of them (7) showed a Downtrend. A.I.dvisor found 151 similar cases when ORYZF's price went up within three months. In out of those 151 cases, ORYZF's price went down during the next month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for ORYZF are